Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $6.89B | $43.86 | 4.35% | $49.69M | 274.13x | 1.60 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.12B | $8.12 | 1.50% | $31.73M | 203.00x | 0.46 | Canada | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $7.73B | $73.23 | 3.21% | $136.81M | 54.24x | 0.24 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $4.91B | $170.57 | 0.49% | $102.07M | 54.67x | 0.12 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $604.90M | $7.78 | 2.10% | $10.34M | 70.73x | 0.48 | United States | ||
| SPRY | ARS PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.37B | $13.92 | -1.56% | $8.37M | 174.00x | 0.37 | United States | ||
| GYRE | GYRE THERAPEUTICS INC | NASDAQ | Biotechnology | $895.87M | $9.57 | 2.68% | $19.63M | 68.36x | 0.43 | United States | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $38.25B | $629.51 | 1.38% | $114.32M | 41.61x | 0.13 | Belgium | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.95B | $24.28 | 2.75% | $254.32M | 17.59x | 0.17 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.69B | $29.44 | 0.27% | $233.41M | 11.50x | 0.52 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.97B | $39.36 | 1.60% | $23.28M | 187.43x | 0.48 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $10.79B | $38.55 | 0.29% | $737.90M | 21.42x | 0.31 | United States | ||
| SRPT | SAREPTA THERAPEUTICS INC | NASDAQ | Biotechnology | $5.90B | $60.85 | -1.07% | $314.67M | 24.64x | 1.59 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $7.49B | $60.82 | 0.41% | $656.54M | 17.38x | 4.67 | United States | ||
| RIGL | RIGEL PHARMACEUTICALS INC | NASDAQ | Biotechnology | $349.58M | $19.57 | 0.82% | $28.51M | 19.77x | 48.87 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $18.86B | $32.71 | 0.52% | $1.08B | 17.04x | 0.76 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $290.94B | $65.16 | 4.06% | $20.43B | 20.58x | 2.25 | Denmark | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $1.02B | $6.92 | 1.32% | $66.07M | 23.86x | 0.37 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.49B | $4.91 | 3.81% | $77.54M | 49.10x | -6.00 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $5.73B | $24.11 | -1.63% | $147.69M | 28.36x | 0.40 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $11.70B | $60.43 | 1.53% | $406.83M | 208.38x | 0.57 | United States | ||
| GNFT | GENFIT SA | NASDAQ | Biotechnology | $202.48M | $4.05 | 10.35% | $9.48M | 119.12x | 1.19 | France | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $2.45B | $31.38 | -0.92% | $54.16M | 98.06x | 0.11 | United States | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | $7.07B | $116.41 | 3.12% | $1.37B | 12.85x | 1.93 | Ireland | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $12.07B | $63.28 | 0.48% | $650.86M | 28.12x | 0.24 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $7.98B | $50.50 | 0.50% | $312.12M | 50.50x | 0.29 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $13.76B | $20.79 | 0.78% | $1.61B | 12.18x | 0.25 | Denmark | ||
| ACAD | ACADIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.41B | $14.43 | -1.57% | $273.96M | 10.53x | 0.62 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $13.51B | $300.76 | 1.25% | $1.65B | 11.38x | 0.14 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $61.42B | $568.91 | -6.87% | $5.53B | 13.62x | 0.28 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.